Peer-reviewedCC BY-NC-NDSignal transduction and targeted therapy
From cryptic exons to neuronal dysfunction: combinatorial antisense makes sense in TAR DNA-binding protein-43 (TDP-43) pathology.
- 1Institute of Neuropathology, Uniklinik RWTH Aachen, Aachen, Germany.
- 2Institute of Neuropathology, Uniklinik RWTH Aachen, Aachen, Germany. [email protected].
Related
- Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction
- Anti-HDGFL2 cryptic protein antibodies provide a sensitive readout of TDP-43 pathology and clinical disease features
- The Impact of Subclinical Thyroid Dysfunction on Cerebrovascular Pathology: A Focus on Carotid Atherosclerosis and Stroke Severity
- TXNRD1-driven enteric glial remodeling promotes neuronal dysfunction in Hirschsprung disease
- MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors
BibTeX
@article{figlia2026from,
title = {{From cryptic exons to neuronal dysfunction: combinatorial antisense makes sense in TAR DNA-binding protein-43 (TDP-43) pathology.}},
author = {Gianluca Figlia and Juliane Bremer},
journal = {Signal transduction and targeted therapy},
year = {2026},
month = oct,
doi = {10.1038/s41392-026-03002-x},
url = {https://europepmc.org/article/MED/42901903},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - From cryptic exons to neuronal dysfunction: combinatorial antisense makes sense in TAR DNA-binding protein-43 (TDP-43) pathology.
AU - Gianluca Figlia
AU - Juliane Bremer
PY - 2026
DA - 2026/10/21
JO - Signal transduction and targeted therapy
DO - 10.1038/s41392-026-03002-x
UR - https://europepmc.org/article/MED/42901903
SN - 2095-9907
SN - 2059-3635
ER -